Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The pericentric inversion of chromosome 16 [inv(16)(p13q22)] is a characteristic karyotypic abnormality associated with acute myeloid leukemia, most commonly of the M4Eo subtype. The 16p and 16q breakpoints were pinpointed by yeast artificial chromosome and cosmid cloning, and the two genes involved in this inversion were identified. On 16q the inversion occurred near the end of the coding region for CBFβ, also known as PEBP2β, a subunit of a heterodimeric transcription factor regulating genes expressed in T cells; on 16p a smooth muscle myosin heavy chain (SMMHC) gene (MYH11) was interrupted. In six of six inv(16) patient samples tested, an in-frame fusion messenger RNA was demonstrated that connected the first 165 amino acids of CBFβ with the tail region of SMMHC. The repeated coiled coil of SMMHC may result in dimerization of the CBFβ fusion protein, which in turn would lead to alterations in transcriptional regulation and contribute to leukemic transformation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A fourth alteration, inv (16), is observed in AML of the M4Eo subtype (French-American-British classification) and indirectly targets AML-1B by fusing CBF-, the gene for the heterodimeric DNA binding partner of AML-1B (71), to the smooth muscle myosin heavy chain gene, MYH11 (35,64).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
In the citing paper
“Consistent with the hypothesis that the inv(16) product titrates AML-1B through physical interactions (35), CBF-- MYH11 represses AML-1B-dependent activation but has only minimal effects on C/EBP-␣.”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
Citations
Cites
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martin-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 803
Translocations Among Antibody Genes in Human Cancer
Leder, P., Battey, J., Lenoir, G., Moulding, C., Murphy, W., Potter, H., Stewart, T., & Taub, R. (1983) · Science · doi:10.1126/science.6356357 · Cited by 712
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., & Shigesada, K. (1993) · Virology · doi:10.1006/viro.1993.1262 · Cited by 493
Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M., & Rowley, J. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309153091103 · Cited by 492
Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., & Speck, N. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3324-3339.1993 · Cited by 435
Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia.
Rowley, J. D. (1973) · PubMed · Cited by 366
Research works printed but not linked: 1
- CALLEN, D.F., Precise localisation of the long arm breakpoint on the inv(16) of ANNL M4Eo and progress towards cloning this breakpoint, AMERICAN JOURNAL OF HUMAN GENETICS 51: A57 (1992).
Cited by
Items 301–400 of 778
Transcriptional Repression of the Neurofibromatosis-1 Tumor Suppressor by the t(8;21) Fusion Protein
Yang, G., Khalaf, W. F., van de Locht, L. T., Jansen, J. H., Gao, M., Thompson, M. A., van der Reijden, B. A., Gutmann, D. H., Delwel, R., Clapp, D. W., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5869-5879.2005 · Cited by 45
Miyagawa, K., Sakakura, C., Nakashima, S., Yoshikawa, T., Kin, S., Nakase, Y., Ito, K., Yamagishi, H., Ida, H., Yazumi, S., et al. (2006) · PubMed · Cited by 45
FISH in genome research and molecular diagnostics
van Ommen, G. B., Breuning, M. H., & Raap, A. K. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80043-3 · Cited by 45
Clinical and prognostic significance of MYH11 in lung cancer
Nie, M., Pan, X., Tao, H., Xu, M., Liu, S., Sun, W., Wu, J., & Zou, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.11478 · Cited by 44
Zhen, T., Cao, Y., Ren, G., Zhao, L., Hyde, R. K., Lopez, G., Feng, D., Alemu, L., Zhao, K., & Liu, P. (2020) · Blood · doi:10.1182/blood.2020007747 · Cited by 44
Self-citationJohansson, B., & Harrison, C. J. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch6 · Cited by 44
Kurokawa, M. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06070 · Cited by 44
Dominant-negative mechanism of leukemogenic PAX5 fusions
Kawamata, N., Pennella, M. A., Woo, J. L., Berk, A. J., & Koeffler, H. P. (2011) · Oncogene · doi:10.1038/onc.2011.291 · Cited by 44
Era, T., Asou, N., Kunisada, T., Yamasaki, H., Asou, H., Kamada, N., Nishikawa, S., Yamaguchi, K., & Takatsuki, K. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870130105 · Cited by 44
Britos-Bray, M. F., Ramírez, M. R., Cao, W., Wang, X., Liu, P. P., Civin, C. I., & Friedman, A. D. (1998) · Blood · doi:10.1182/blood.v92.11.4344 · Cited by 44
Self-citationSacchi, N., Nisson, P. E., Watkins, P. C., Faustinella, F., Wijsman, J., & Hagemeijer, A. (1994) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870110405 · Cited by 43
Detection and monitoring of minimal residual disease by quantitative real-time PCR
Schüler, F., & Dölken, G. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.05.045 · Cited by 43
Blake, T. B., Adya, N., Kim, C., Oates, A. C., Zon, L. I., Chitnis, A. B., Weinstein, B. M., & Liu, P. P. (2000) · Blood · doi:10.1182/blood.v96.13.4178 · Cited by 43
Self-citationKohzaki, H., Ito, K., Huang, G., Wee, H., Murakami, Y., & Ito, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202735 · Cited by 43
Advances in treating acute myeloid leukemia
Showel, M. M., & Levis, M. J. (2014) · F1000Prime Reports · doi:10.12703/p6-96 · Cited by 42
Gene Duplication and Gene Fusion Are Important Drivers of Tumourigenesis during Cancer Evolution
Glenfield, C., & Innan, H. (2021) · Genes · doi:10.3390/genes12091376 · Cited by 42
OGG1 is a novel prognostic indicator in acute myeloid leukaemia
Liddiard, K., Hills, R. K., Burnett, A. K., Darley, R. L., & Tonks, A. (2009) · Oncogene · doi:10.1038/onc.2009.462 · Cited by 42
Transcriptional network control of normal and leukaemic haematopoiesis
Sive, J. I., & Göttgens, B. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.06.021 · Cited by 42
Liu, Y.-N., Kang, B.-B., & Chen, J. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207022 · Cited by 42
The Runt Domain Transcription Factor, PEBP2/CBF, and its Involvement in Human Leukemia
Ito, Y., & Bae, S.-C. (1997) · Oncogenes as Transcriptional Regulators · doi:10.1007/978-3-0348-8934-6_4 · Cited by 41
van der Reijden, B. A., Simons, A., Luiten, E. B., van der Poel, S. C. P. A. M., Hogenbirk, P., Tönnissen, E., Valk, P. J. M., Löwenberg, B., de Greef, G. E., Breuning, M. H., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03738.x · Cited by 41
Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice
Yamashita, N., Osato, M., Huang, L., Yanagida, M., Kogan, S. C., 岩崎, 正., Nakamura, T., Shigesada, K., Asou, N., & Ito, Y. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05793.x · Cited by 41
Krauter, J., Hoellge, W., Wattjes, M. P., Nagel, S., Heidenreich, O. T., Bunjes, D. W., Ganser, A., & Heil, G. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1100 · Cited by 40
Martín, G., Barragán, E., Bolufer, P., Chillón, C., García‐Sánz, R., Gómez, T., Brunet, S., González, M., & Sanz, M. Á. (2000) · PubMed · Cited by 39
Look, A. T. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60709-5 · Cited by 40
Aneurysmal bone cyst with chromosomal changes involving 7q and 16p
Baruffi, M. R., Neto, J. B., Barbieri, C. H., & Casartelli, C. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00453-8 · Cited by 38
Mancini, M., Cedrone, M., Diverio, D., Emanuel, B. S., Stul, M. S., Vranckx, H., Brama, M., Mr, D. C., Nanni, M., Fazi, F., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401678 · Cited by 38
Pan, Y., Matsuyama, H., Wang, N., Yoshihiro, S., Häggarth, L., Li, C., Tribukait, B., Ekman, P., & Bergerheim, U. S. R. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980615)36:1<31::aid-pros5>3.0.co;2-e · Cited by 38
Involvement of the TEL Gene in Hematologic Malignancy by Diverse Molecular Genetic Mechanisms
Golub, T. R., Barker, G. F., Stegmaier, K., & Gilliland, D. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_28 · Cited by 38
Le, X., Claxton, D. F., Kornblau, S. M., Fan, Y., Mu, Z., & Chang, K.-S. (1998) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1998.tb01027.x · Cited by 38
Self-citationBrunner, A. M., Blonquist, T. M., Sadrzadeh, H., Perry, A. M., Attar, E. C., Amrein, P. C., Ballen, K. K., Chen, Y., Neuberg, D. S., & Fathi, A. T. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.04.001 · Cited by 37
Increased Dosage of the RUNX1/AML1 Gene: A Third Mode of RUNX Leukemia?
Osato, M., & Ito, Y. (2005) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v15.i3.40 · Cited by 37
Kaminker, J. S., Singh, R., Lebestky, T., Yan, H., & Banerjee, U. K. (2001) · Development · doi:10.1242/dev.128.14.2639 · Cited by 37
Chen, G., Huang, L. D., Zeng, W., & Manji, H. K. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570100222x · Cited by 37
van der Reijden, B., Dauwerse, J., Wessels, J. A., Beverstock, G. C., Hagemeijer, A., van Ommen, G. B., & Breuning, M. H. (1993) · Blood · doi:10.1182/blood.v82.10.2948.bloodjournal82102948 · Cited by 37
Estecio, M. R., Maddipoti, S., Bueso-Ramos, C., Dinardo, C. D., Yang, H., Wei, Y., Kondo, K., Fang, Z., Stevenson, W. S., Chang, K.-S., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13299 · Cited by 36
The RUNX Family of Proteins, DNA Repair, and Cancer
Krishnan, V. (2023) · Cells · doi:10.3390/cells12081106 · Cited by 36
Xue, L., Pulikkan, J. A., Valk, P. J. M., & Castilla, L. H. (2014) · Blood · doi:10.1182/blood-2013-12-541730 · Cited by 36
Somatic mutation analysis of MYH11in breast and prostate cancer
Alhopuro, P., Karhu, A., Winqvist, R., Waltering, K. K., Visakorpi, T., & Aaltonen, L. A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-263 · Cited by 36
Miller, J., Stacy, T., Liu, P. P., & Speck, N. A. (2001) · Blood · doi:10.1182/blood.v97.8.2248 · Cited by 36
Self-citationMolecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera
Huang, G., Shigesada, K., Wee, H., Liu, P. P., Osato, M., & Ito, Y. (2003) · Blood · doi:10.1182/blood-2003-07-2188 · Cited by 36
Self-citationTHE MANAGEMENT OF PATIENTS WITH LEUKAEMIA: THE ROLE OF CYTOGENETICS IN THIS MOLECULAR ERA
Harrison, C. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01801.x · Cited by 36
Ito, Y. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01261402 · Cited by 36
Acute leukemias VII : experimental approaches and novel therapies
Hiddemann, W. (1998) · Springer eBooks · Cited by 36
A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology
Skayneh, H., Jishi, B., Hleihel, R., Hamieh, M., Darwiche, N., Bazarbachi, A. A., El-Sabban, M. E., & Hajj, H. E. (2019) · Genes · doi:10.3390/genes10080614 · Cited by 35
Nakao, M., Horiike, S., Fukushima‐Nakase, Y., Nishimura, M., Fujita, Y., Taniwaki, M., & Okuda, T. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04966.x · Cited by 34
“In addition, the gene that encodes its heterodimer partner, CBFb, has also been shown to be the target of another leukaemia-associated chromosome aberration, inv(16) (Liu et al, 1993).”
BackgroundLoss of FBXO9 Enhances Proteasome Activity and Promotes Aggressiveness in Acute Myeloid Leukemia
Hynes-Smith, R. W., Swenson, S. A., Vahle, H., Wittorf, K. J., Caplan, M., Amador, C., Hyde, R. K., & Buckley, S. M. (2019) · Cancers · doi:10.3390/cancers11111717 · Cited by 34
Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML
Caplan, M., Wittorf, K. J., Weber, K. K., Swenson, S. A., Gilbreath, T. J., Hynes-Smith, R. W., Amador, C. C., Hyde, R. K., & Buckley, S. M. (2022) · Leukemia · doi:10.1038/s41375-022-01518-z · Cited by 34
Qin, Y., Xu, L., Chen, H., Jiang, Q., Wang, Y., Jiang, H., Zhang, X., Han, W., Chen, Y., Wang, F., et al. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1032964 · Cited by 34
Molecular characterization of acute myeloid leukemia and its impact on treatment
Frankfurt, O., Licht, J. D., & Tallman, M. S. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f10e55 · Cited by 34
Dombret, H., Preudhomme, C., & Boissel, N. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283257b18 · Cited by 34
Xia, D., Zhang, Y., Huang, X., Sun, Y., & Zhang, H. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.07.020 · Cited by 34
Zhang, L., Li, Z., Yan, J., Pradhan, P., Corpora, T., Cheney, M. D., Bravo, J., Warren, A. J., Bushweller, J. H., & Speck, N. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303972200 · Cited by 34
Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease
Weide, R., Rieder, H., Mehraein, Y., Wolf, M., Kaiser, U., Seifart, U., Görg, C., & HAVEMANN, K. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-1991.x · Cited by 34
Jackson, M. E., & Campo, M. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6038-6046.1995 · Cited by 34
Detection of Chromosomal Translocations :in Leukemia-Lymphoma Cells by Polymerase Chain Reaction
Drexler, H. G., Borkhardt, A., & Janssen, J. W. G. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509112194 · Cited by 34
Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis
Hussey, D. J., & Dobrovic, A. (2002) · Blood · doi:10.1182/blood.v99.3.1097 · Cited by 34
Pioneer factors in development and cancer
Sunkel, B. D., & Stanton, B. Z. (2021) · iScience · doi:10.1016/j.isci.2021.103132 · Cited by 33
RUNX genes find a niche in stem cell biology
Appleford, P. J., & Woollard, A. C. S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22249 · Cited by 33
Khan, A., Hyde, R. K., Dutra, A., Mohide, P., & Liu, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31479 · Cited by 33
Self-citationChd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11
Zhen, T., Kwon, E. M., Zhao, L., Hsu, J., Hyde, R. K., Lu, Y., Alemu, L., Speck, N. A., & Liu, P. (2017) · Blood · doi:10.1182/blood-2017-04-780106 · Cited by 33
Self-citationKummalue, T., Lou, J., & Friedman, A. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8278-8291.2002 · Cited by 33
Wijmenga, C., Gregory, P. E., Hajra, A. K., Schröck, E., Ried, T., Eils, R., Liu, P. P., & Collins, F. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1630 · Cited by 33
Self-citationMitterbauer, M., Laczika, K. F., Novak, M., Mitterbauer, G., Hilgarth, B., Pirc‐Danoewinata, H., Schwarzinger, I., Haas, O. A., Fonatsch, C., Lechner, K., et al. (2000) · American Journal of Clinical Pathology · doi:10.1309/d94u-351n-ht3d-f1f3 · Cited by 33
van der Kolk, D. M., Vellenga, E., van der Veen, A. Y., Noordhoek, L., Timmer‐Bosscha, H., Ossenkoppele, G. J., Raymakers, R. A. P., Müller, M. M., van den Berg, E., & de Vries, E. G. E. (2000) · Blood · doi:10.1182/blood.v95.11.3514 · Cited by 33
Sarriera, J., Albitar, M. X., Estrov, Z. E., Gidel, C., Aboul-Nasr, R., Manshouri, T., Kornblau, S. M., Chang, K. S., Kantarjian, H. M., & Estey, E. H. (2001) · Leukemia · doi:10.1038/sj.leu.2401951 · Cited by 33
Identification of immune-related genes as prognostic factors in bladder cancer
Zhu, J., Wang, H., Ma, T., He, Y. L., Shen, M., Song, W., Wang, J., Shi, J., Wu, M., Liu, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76688-w · Cited by 32
Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered
van der Reijden, B. A., Dauwerse, H. G., Giles, R. H., Jagmohan–Changur, S., Wijmenga, C., Liu, P. P., Smit, B., Wessels, H. W., Beverstock, G. C., Jotterand-Bellomo, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202321 · Cited by 32
Self-citationRegain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition
Kuo, Y., Qi, J., & Cook, G. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.02.007 · Cited by 31
Minimal residual disease in acute myeloid leukaemia
Yin, J. A. L. (2002) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2002.0188 · Cited by 31
Sequence‐Based, in situ detection of chromosomal abnormalities at high resolution
Knoll, J. H. M., & Rogan, P. K. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20123 · Cited by 31
Sykes, P. J., Hooker, A. M., Harrington, C. S., Jacobs, A. K., Kingsbury, L., & Morley, A. A. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00213-3 · Cited by 31
Chromosomal Rearrangements in Childhood Acute Myeloid Leukemia and Myelodysplastic Syndromes
Martinez-Climent, J. A., & Garcfa-Conde, J. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199903000-00004 · Cited by 31
Genetic compensation of RUNX family transcription factors in leukemia
Kamikubo, Y. (2018) · Cancer Science · doi:10.1111/cas.13664 · Cited by 30
Core-Binding Factor Influences the Disease Specificity of Moloney Murine Leukemia Virus
Lewis, A. F., Stacy, T., Green, W. R., Taddesse-Heath, L., Hartley, J. W., & Speck, N. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5535-5547.1999 · Cited by 30
Allogeneic Hematopoietic Cell Transplantation for Adult Patients With Acute Myeloid Leukemia
Stockerl-Goldstein, K. E., & Blume, K. G. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch75 · Cited by 30
Contribution of oncogenes and tumor suppressor genes to myeloid leukemia
Wolff, L. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00006-1 · Cited by 30
Hiebert, S. W., Reed-Inderbitzin, E. F., Amann, J. M., Irvin, B. J., Durst, K. L., & Linggi, B. E. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00021-4 · Cited by 30
Myelodysplastic Syndrome with Hypereosinophilia and a Nonrandom Chromosomal Abnormality dic(1;7)
Forrest, D. L., Horsman, D. E., Jensen, C. L., Berry, B. R., Dalal, B. I., Barnett, M. J., & Nantel, S. H. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00055-7 · Cited by 30
Coluccio, L. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38062-5_12 · Cited by 29
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Zhou, W., Yu, J., Li, Y., & Wang, K. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00353-3 · Cited by 29
Davis, J. N., Rogers, D. L., Adams, L. K., Yong, T., Jung, J. S., Cheng, B., Fennell, K. A., Borazanci, E. H., Moustafa, Y. W., Sun, A., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22298 · Cited by 29
The Genetics of Male Fertility—From Basic Science to Clinical Evaluation
Pastuszak, A. W., & Lamb, D. J. (2012) · Journal of Andrology · doi:10.2164/jandrol.112.017103 · Cited by 29
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma
Ning, X., & Deng, Y. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s131386 · Cited by 29
Akamatsu, Y., Tsukumo, S., Kagoshima, H., Tsurushita, N., & Shigesada, K. (1997) · Gene · doi:10.1016/s0378-1119(96)00644-0 · Cited by 29
Zent, C. S., Kim, N., Hiebert, S. W., Zhang, D., Tenen, D. G., Rowley, J. D., & Nucifora, G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_24 · Cited by 29
Kuo, Y., Gerstein, R. M., & Castilla, L. H. (2007) · Blood · doi:10.1182/blood-2007-07-104422 · Cited by 28
Marcucci, G., Caligiuri, M. A., & Bloomfield, C. D. (2003) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2003.00131.x · Cited by 28
Regulation of Immature Myeloid Cell Differentiation by PEBP2/CBF, MYB, C/EBP and ETS Family Members
Friedman, A. D. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_15 · Cited by 28
TEL GENE REARRANGEMENTS IN MYELOID MALIGNANCY
Golub, T. R. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70490-1 · Cited by 28
Retroviral insertional mutagenesis identifies oncogene cooperation
Nakamura, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00011.x · Cited by 27
Sørensen, K. D., Quintanilla‐Martínez, L., Kunder, S., Schmidt, J., & Pedersen, F. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13216-13231.2004 · Cited by 27
Transcriptional Control of Hematopoiesis
Robb, L. G., Elefanty, A. G., & Begley, C. G. (1999) · Elsevier eBooks · doi:10.1016/b978-012624960-6/50003-0 · Cited by 27
Ethelberg, S., Hallberg, B., Lovmand, J., Schmidt, J., Luz, A., Grundström, T., & Pedersen, F. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1196-1206.1997 · Cited by 27
CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice
Cai, Q., Jeannet, R., Hua, W.-K., Cook, G., Zhang, B., Qi, J., Liu, H., Li, L., Chen, C., Marcucci, G., et al. (2016) · Blood · doi:10.1182/blood-2016-01-693119 · Cited by 26
Duan, W., Liu, X., Jia, J., Wang, J., Gong, L., Jiang, Q., Zhao, T., Wang, Y., Zhang, X., Xu, L., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16745 · Cited by 26
Granger, S. W., & Fan, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8961-8970.1998 · Cited by 26
Brady, H. J. M. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04663.x · Cited by 26
Osato, M., Asou, N., Okubo, T., Nishimura, S., Yamasaki, H. R., Era, T., Suzushima, H., Kawano, F., Matsuoka, R., Oka, H., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1012917.x · Cited by 26
Inversion due to intrachromosomal recombination produced by carcinogens in a transgenic mouse model
Sykes, P. J., Hooker, A. M., & Morley, A. A. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00084-6 · Cited by 26
Metadata
- Authors
- Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Science
- Published
- 1993-08-20
- Volume
- 261
- Issue
- 5124
- Pages
- 1041-1044
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2047591593
- Cited by
- 732
- References
- 37
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 7 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 13 · 2018: 8 · 2017: 24 · 2016: 8 · 2015: 23 · 2014: 18 · 2013: 14 · 2012: 15
- FWCI
- 25.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-55164, P01CA055164)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- acute myeloid leukemia, inv(16)(p13q22), CBFβ, smooth muscle myosin heavy chain, MYH11, gene fusion, transcription factors, coiled-coil dimerization, leukemic transformation, karyotype abnormalities
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 16, Cloning, Molecular, Cosmids, DNA-Binding Proteins, Humans, Chromosome Inversion, Molecular Sequence Data, Muscle, Smooth, Myosins, Neoplasm Proteins, Transcription Factors, Restriction Mapping, Leukemia, Myelomonocytic, Acute, Polymerase Chain Reaction, In Situ Hybridization, Fluorescence, Transcription Factor AP-2, Core Binding Factor beta Subunit, Core Binding Factor Alpha 1 Subunit, Core Binding Factors, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.